Ankylosing Spondylitis (AS) is a a chronic inflammatory disease for the axial skeleton the common symptom is lower back pain. The autoimmune disease affects the skeletal structure and in severe cases can fuse the spines vertebrae together. There are many doctors (Rheumatologists) in the world who specialise in the treatment of AS, however in India there are a new form of treatment which is heavily regulated in the western world.
This form of treatment is mesenchymal stem cells (MSC’s) this offers new promise in curing autoimmune diseases like AS. In India there is a growing industry of stem cell therapy clinics located throughout the entire India land mass, including Mumbai and New Delhi.
Dr.Geeta Shroff & Dr Ashish Verma are leading researchers / physicians in the application of MSC’s for many diseases including Ankylosing Spondylitis. The Indian medical tourist market has been growing over the past few years and there is a combination of reasons why this is. Firstly the prices of Mesenchymal stem cell therapy is a fraction of the cost experienced in the western world. Secondly, the Indian medical industry is more liberally controlled than the western countries. Embryonic stem cells research and treatment of patients with chronic ailments are allowed and no major legal blocks to the industry are existent.
Do you research of these stem cell therapy clinics before you dive into the treatment.